申请人:Boehringer Mannheim G.m.b.H.
公开号:US03932411A1
公开(公告)日:1976-01-13
New 3,4-dihydro-2H-naphthalene-1-one-5-oxypropyl-piperazine derivatives of the formula: ##SPC1## Wherein A is hydrogen or hydroxyl; X is hydrogen, halogen, alkyl or Alkoxy; and n is 0, 1 or 2; And the pharmacologically compatible salts thereof; are outstandingly effective in blood pressure depressing and tranquilizing or sedative therapy; further, these compounds have antioedematous action and reduce capillary permeability.
新的3,4-二氢-2H-萘酮-5-氧丙基-哌嗪衍生物的化学式如下:##SPC1## 其中A为氢或羟基;X为氢、卤素、烷基或烷氧基;n为0、1或2;以及其药理学兼容盐;在降低血压和镇静或催眠疗法方面具有杰出的效果;此外,这些化合物具有抗水肿作用并减少毛细血管通透性。